Not only does cancer have a major impact on families but also the community in general. For that reason, researchers, donors, scientists, and educators have come together to find viable treatments and therapies. Today, there are many contributors dedicated to finding cancer treatment and therapies. One such contributor is Eric Lefkofsky.

Background Information

Eric Lefkofsky was born to Jewish parents, in Michigan. His father, Bill, was a best structural engineer while his mother, Sandy, was a school teacher. Lefkofsky went to Tamarack Camps where he served as staff. He then graduated from the prestigious Southfield-Lathrup High School. He would later join the University of Michigan followed by the University of Michigan Law School for his Juris Doctor.

Career

After graduating from law school, Lefkofsky delved into various entrepreneurial ventures before co-founding Tempus. Today, he is the head cheerleader of the company. He oversees operations by streamlining various departments.

More on Tempus

Tempus reiterates the adage if you want to succeed, you should work with your team. The company is a collective of a combined knowledge base. With the leadership of Eric Lefkofsky, the management attacks cancer through a broad spectrum of various platforms.

Mission and Vision

Tempus was built to generate clinical trials. These clinical trials seek new treatment procedures to make clients feel better regarding their health status. The organization has a professional team with excellent expertise to battle cancer. Besides, Tempus has also developed a modern platform that analyses a patient’s detailed profiles on a personal level. The platform later compares these profiles with different databases that belong to patients who have been undergoing treatment for some time. Physicians help to determine the possible treatment methods to apply as these treatments usually have a higher probability of being successful. In addition, the platform integrates different molecular variables generated through analyzing the samples of tumors as well as healthy tissues.

Overview

While Tempus may be succeeding in generating tailored treatment, and therapies for cancer, it also encounters some challenges. One of these challenges is processing big data. When the management realized that many facilities encountered this challenge, it partnered with like-minded companies to establish a platform that would help leverage learning machine software coupled with algorithms of new patients. Through this platform, Tempus delivers tailored treatment options to patients.